The 1997 founding of the drug development company Therapeutics, Inc. was fostered by the strong support for Dr. Dan Piacquadio's consulting practice that had existed since 1985.  Formerly as the director of the UCSD Dermatology Product Research Group for 10 years, Dr. Piacquadio oversaw in vivo and in vitro labs, development services and a clinical research group conducting studies in clinical Phases I-IV. Through his experience in the dermatology drug development arena, Dr. Piacquadio realized a need for diverse development consulting services. He founded Therapeutics to address the unique needs of such clients. The initial targets included a) dermatology sales and marketing organizations looking for turn-key development services; b) dermatology companies in need of strategic clinical or development expertise to supplement their own in-house resources; and c) investment bankers and venture capitalists requiring expert opinion and due diligence support for the evaluation of new business opportunities.

Through the years, Therapeutics’ mission has remained unchanged. Therapeutics is committed to being the preferred partner. We provide unwavering commitment and service, taking products from concept to the bench top, to proof-of-concept and then, if appropriate, through clinical development, regulatory review and approval.

Therapeutics is not a discovery research company, nor do we commercialize products. Instead we focus on providing unsurpassed services and the development and approval of commercially successful products.

Therapeutics seamlessly works with a trusted network of partners who provide technical capabilities that lie outside of our areas of concentration. We frequently collaborate with Therapeutics Clinical Research (TCR), which was spun off from Therapeutics Incorporated as an independent company to specialize in clinical research.

In the recent past, Therapeutics studies and programs have included development of drugs and/or devices for: